Related Experiment Video

Updated: Jun 5, 2026

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis

Boda Zhou1, Andriana Margariti, Lingfang Zeng

  • 1Cardiovascular Division, King's College London BHF Centre, 125 Coldharbour Lane, London SE5 9NU, UK.

Cardiovascular Research
|January 15, 2011
PubMed

Insights

Histone deacetylases (HDACs) regulate gene expression and are crucial in cardiovascular diseases. HDAC inhibitors show promise for treating atherosclerosis and related conditions.

Area of Science:

  • Biochemistry
  • Epigenetics
  • Cardiovascular Biology

Background:

  • Histone deacetylases (HDACs) are enzymes involved in epigenetic gene regulation.
  • HDACs play significant roles in cancer and neurological disorders.
  • Emerging evidence highlights HDACs' critical involvement in arteriosclerosis.

Purpose of the Study:

  • To review the impact of HDACs and their inhibitors on endothelial and smooth muscle cell functions.
  • To discuss the recent findings on HDACs' roles in stem cell differentiation and atherosclerosis.
  • To evaluate HDACs as potential therapeutic targets for cardiovascular diseases.

Main Methods:

  • Literature review of studies on HDACs and cardiovascular disease.
  • Analysis of HDACs' effects on cell proliferation, migration, and apoptosis.
  • Synthesis of recent research on HDACs, stem cells, and atherosclerosis.

Main Results:

  • HDACs influence the proliferation, migration, and apoptosis of key cardiovascular cell types.
  • HDACs impact stem cell differentiation relevant to cardiovascular health.
  • HDACs are implicated in the pathogenesis of atherosclerosis.

Conclusions:

  • HDACs are critical regulators in cardiovascular biology.
  • HDAC inhibitors represent a promising therapeutic strategy for arteriosclerosis.
  • Targeting HDACs may offer new avenues for treating cardiovascular diseases.

More Related Videos

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates

Published on: February 27, 2016

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...